MIT
Delphia Therapeutics Launches With $67M Series A Financing
The firm is developing a new class of drugs that kill cancer cells by over-activating oncogene pathways.
Biswas Family Foundation, Milken Institute Award $14M in Computational Biology Grants
The funding will support researchers developing artificial intelligence and other computational tools for clinical applications including cancer diagnosis and care.
A recent study showed that the firm's technology could predict glioblastoma patients' chemo responses as well or better than an established genomic biomarker.
ReviveMed, Bristol Myers Squibb to Study Metabolomics for Cancer Immunotherapy
The partners will use ReviveMed's AI-driven platform to better understand mechanisms of immunotherapy response and resistance in cancer patients.
Gray Foundation Awards $25M in Cancer Research Grants
The grant recipients will receive up to $5 million each and are led by scientists at institutions including Harvard Medical School and the Cleveland Clinic.